Summary by Futu AI
Aidigong Maternal and Infant Health Limited ("Aidigong") announced its interim business performance for the six months ended June 30, 2024. During the reporting period, the company's revenue decreased by 10.6% year-on-year, to approximately 0.275 billion Hong Kong dollars, with the gross margin dropping from 30.3% to 25.5%, and the net loss increased by approximately 16.43 million Hong Kong dollars to around 39.35 million Hong Kong dollars. Both basic and diluted losses per share were 0.81 Hong Kong cents. In the period, Aidigong's postpartum care service business revenue declined, mainly affected by factors such as the depreciation of the Renminbi against the Hong Kong dollar, macroeconomic impact, and low initial occupancy rates at newly opened postpartum care centers. The company proposed a share consolidation plan after the reporting period, which took effect on July 29, 2024, combining every 40 existing shares into 1. Additionally, on June 20, 2024, the company entered into a subscription agreement with placement agents to conduct new share placement transactions.
